Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Vanda Falls Again As Teva, US FDA Win Judgment In Tasimelteon Approval Case
Feb 25 2025
•
By
Dean Rudge
The court ruled against Vanda in its three challenges of the FDA approval decision.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Generics
More from Legal & IP